Coloplast A/S

Research Coloplast A/S (CBHD) on Bullrun: valuation model: 38.1% overvalued, market cap EUR 11.50B, P/E 40.8, dividend yield 6.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCBHD
• ExchangeXETRA
• CountryDenmark
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyEUR
• Valuation signal38.1% overvalued
• Market capEUR 11.50B
• P/E40.8
• Dividend yield6.0%
• Financial periodFY2025

Valuation Snapshot

Bullrun's latest valuation model marks Coloplast A/S as 38.1% overvalued; latest market cap is EUR 11.50B; P/E is 40.8; dividend yield is 6.0%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies;

Frequently asked questions

Is Coloplast A/S overvalued or undervalued?

Bullrun's valuation model currently marks Coloplast A/S as 38.1% overvalued.

What is Coloplast A/S's market cap?

Coloplast A/S's market capitalization is EUR 11.50B.

What is Coloplast A/S's P/E ratio?

Coloplast A/S's price-to-earnings (P/E) ratio is 40.8.

Does Coloplast A/S pay a dividend?

Coloplast A/S has a dividend yield of 6.0%.

What does Coloplast A/S do?

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.